期刊文献+

微血管密度与子宫内膜癌关系的研究

The study of the density of microvessels in endometrial carcinoma
下载PDF
导出
摘要 目的 探讨微血管密度(MVD)与人子宫内膜癌的临床病理特征和无瘤生存率的关系;方法 采用免疫组织化学方法检测34例子宫内膜癌组织中.MVD的表达水平;结果 在肿瘤直径≥2cm的MVD高密度率高于肿瘤直径<2 cm(84.62%VS 66.67%,P=0.1300 4);Ⅲ期MVD的高密度率明显高于Ⅰ期和Ⅱ期的总MVD高密度率(100.00%VS 74.74%,P=0.001 0);MVD在发病年龄<50岁的高密度率明显高于发病年龄≥50岁(100.00%VS78.33%.P=0.016 0);34例患者有3例有淋巴结转移,其MVD均为高密度;NVD与病理分级、无瘤生存率无关。结论子宫内膜癌中MVD可能具有促肿瘤生长、转移的作用并具有年龄依赖性。 Objective To study the relationships between the expressions of the density of microvessels (MVD) of the tumors and the clinicopathologic features, disease - free survival rates in endometrial carcinoma. Methods Specimens from 34 cases of endometrial carcinoma were studied by immunohistochemical stainings with monoclonal antibodies to MVD. Results MVD high- density rates were found higher in the following cases, tumor size ^2 cm than in that < 2 cm (84.62% vs 66.67% , P =0.000 4) , stage Ⅲ than in stage Ⅰ-Ⅱ (100.00% vs 74.74% , P = 0.001 0) and age < 50 than in age≥50 (100.00% vs 78.33% , P = 0.016 0) . 3 cases with lymph node metastasis all showed high- density MVD. There was no significant correlation between MVD and histologic grade or disease - free survival rate. Conclusions MVD was associated with tumor growth , metastasis and was age - dependent in endometrial carcinoma.
出处 《中国妇产科临床杂志》 2001年第1期14-15,52,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 子宫内膜癌 微血管密度 血管增生 免疫组织化学 Endometrial carcinoma Density of microvessels Angiogenesis Immunohistochemical staining
  • 相关文献

参考文献12

  • 1[1]Matsushita S, Nitanda T, Furukawa T, et al. The effect of a thymidine phosphorylase inhibitoron angiogenesis and apoptosis in tumors. Cancer Res, 1999, 59: 1911- 1916
  • 2[2]Folkman J. What is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst, 1990, 82:4 - 6
  • 3[3]Fujiwaki R, Hata K, Iida K, et al. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer. Gynecol Oncol,1998, 68: 247 - 252
  • 4[4]Kaku T, Kamura T, Kinukawa N, et al. Angiogenesis in endometrial carcinoma. Cancer, 1997, 80: 741- 747
  • 5[5]Kischner CV, Alanis - Amezcua JM, Martin VG, et al. Angiogenesis factor in endometrial carcinoma: A new prognostic indicator? Am J Obstet Gynecol, 1996, 174: 1879-1884
  • 6[6]Abulafia O, Triest WE, Sherer DM, et al. Angiogenesis in endometrial hyperplasia and stage Ⅰ endometrial carcinoma. Obstet Gynecol, 1995 ,86: 479- 485
  • 7[7]Wagatsuma S, Konno R, Sato S, et al. Tumor angiogenesis, hepatocyte growth factor and c - Met expression in endometrial carcinoma. Cancer ,1998, 82: 520- 530
  • 8[8]Folkman J. Clinical applications of research on angiogenesis. N Engl J Med, 1995, 333:1757-1762
  • 9[9]Heimann R, Ferguson DJ, Hellman S. The relationship between nm23,angiogenesis and the metastatic prodivity of node - negative breast cancer.Cancer Res, 1998 , 58: 2766-2771
  • 10秦净,徐世中,张轶斌,吴肇汉,孙宝荣,施达仁,陆洪芬.胃癌组织微血管密度的临床病理意义[J].肿瘤,1999,19(3):166-168. 被引量:9

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部